QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ubs-maintains-buy-on-lifestance-health-gr-raises-price-target-to-9

UBS analyst Kevin Caliendo maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $8.5 to $9.

 lifestance-health-gr-affirms-fy2025-sales-guidance-of-1400b-1440b-vs-1413b-est

2025 GuidanceLifeStance is providing the following outlook for 2025:The Company is reiterating full year revenue of $1.40 billi...

 ubs-upgrades-lifestance-health-gr-to-buy-announces-85-price-target

UBS analyst Kevin Caliendo upgrades LifeStance Health Gr (NASDAQ:LFST) from Neutral to Buy and announces $8.5 price target.

 lifestance-health-gr-sees-q2-sales-332000m-352000m-vs-35276m-est

LifeStance Health Gr (NASDAQ:LFST) sees Q2 sales of $332.000 million-$352.000 million vs $352.76 million analyst estimate.

 lifestance-health-gr-affirms-fy2025-sales-guidance-of-140b-144b-vs-142b-est

LifeStance Health Gr (NASDAQ:LFST) affirms FY2025 sales outlook from $1.40 billion-$1.44 billion to $1.40 billion-$1.44 billion...

 lifestance-health-gr-q1-sales-33297m-beat-33290m-estimate

LifeStance Health Gr (NASDAQ:LFST) reported quarterly sales of $332.97 million which beat the analyst consensus estimate of $33...

 keybanc-initiates-coverage-on-lifestance-health-gr-with-overweight-rating-announces-price-target-of-9

Keybanc analyst Steve Dechert initiates coverage on LifeStance Health Gr (NASDAQ:LFST) with a Overweight rating and announc...

 canaccord-genuity-initiates-coverage-on-lifestance-health-gr-with-buy-rating-announces-price-target-of-8

Canaccord Genuity analyst Richard Close initiates coverage on LifeStance Health Gr (NASDAQ:LFST) with a Buy rating and annou...

 lifestance-health-gr-q4-2024-gaap-eps-001-beats-004-estimate-sales-32550m-beat-31372m-estimate

LifeStance Health Gr (NASDAQ:LFST) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of ...

 lifestance-names-dave-bourdon-as-ceo-ken-burdick-named-as-executive-chairman

Bourdon, who joined LifeStance as Chief Financial Officer in 2022, is succeeding Ken Burdick, who is retiring from his role as ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION